Online-Trading Portfolio-Tracker Research Back-Office MF-Tracker
BSE Prices delayed by 5 minutes... << Prices as on May 02, 2024 - 3:59PM >>   ABB 6679.35 [ 2.09 ]ACC 2531 [ -0.01 ]AMBUJA CEM 625.4 [ 0.92 ]ASIAN PAINTS 2973.8 [ 3.36 ]AXIS BANK 1149.75 [ -1.41 ]BAJAJ AUTO 9103.8 [ 2.20 ]BANKOFBARODA 279.3 [ -0.82 ]BHARTI AIRTE 1306.15 [ -1.26 ]BHEL 292.65 [ 3.91 ]BPCL 634.8 [ 4.45 ]BRITANIAINDS 4760 [ -0.22 ]CIPLA 1419.55 [ 1.31 ]COAL INDIA 453.25 [ -0.23 ]COLGATEPALMO 2813.1 [ -0.41 ]DABUR INDIA 524.3 [ 3.30 ]DLF 895.7 [ 0.41 ]DRREDDYSLAB 6260 [ 0.88 ]GAIL 205 [ -1.91 ]GRASIM INDS 2436 [ 1.05 ]HCLTECHNOLOG 1360.4 [ -0.52 ]HDFC 2729.95 [ -0.62 ]HDFC BANK 1533 [ 1.05 ]HEROMOTOCORP 4568.95 [ 0.58 ]HIND.UNILEV 2225.45 [ -0.24 ]HINDALCO 643.75 [ -0.02 ]ICICI BANK 1139.9 [ -1.05 ]IDFC 121.4 [ -0.25 ]INDIANHOTELS 575.45 [ -0.23 ]INDUSINDBANK 1505.2 [ -0.69 ]INFOSYS 1414.85 [ -0.44 ]ITC LTD 439.1 [ 0.80 ]JINDALSTLPOW 943 [ 1.28 ]KOTAK BANK 1575.8 [ -2.95 ]L&T 3597.6 [ 0.10 ]LUPIN 1647.75 [ 0.14 ]MAH&MAH 2180 [ 1.10 ]MARUTI SUZUK 12758.05 [ -0.38 ]MTNL 38.04 [ -2.34 ]NESTLE 2509.5 [ 0.14 ]NIIT 105.25 [ -0.47 ]NMDC 259.1 [ 1.89 ]NTPC 369.35 [ 1.72 ]ONGC 282.65 [ -0.07 ]PNB 138 [ -2.20 ]POWER GRID 313.45 [ 3.91 ]RIL 2932.1 [ 0.03 ]SBI 830.05 [ 0.53 ]SESA GOA 410.7 [ 3.22 ]SHIPPINGCORP 228.5 [ 0.35 ]SUNPHRMINDS 1520 [ 1.18 ]TATA CHEM 1100.7 [ 2.65 ]TATA GLOBAL 1091.7 [ -1.46 ]TATA MOTORS 1027.95 [ 1.99 ]TATA STEEL 167.35 [ 1.45 ]TATAPOWERCOM 457.7 [ 1.91 ]TCS 3863.75 [ 1.08 ]TECH MAHINDR 1266.9 [ 0.39 ]ULTRATECHCEM 9976.95 [ 0.10 ]UNITED SPIRI 1198.4 [ 1.90 ]WIPRO 457.25 [ -1.09 ]ZEETELEFILMS 143.9 [ -2.11 ] BSE NSE
You can view the entire text of Notes to accounts of the company for the latest year

BSE: 530233ISIN: INE292C01011INDUSTRY: Pharmaceuticals

BSE   ` 253.40   Open: 230.40   Today's Range 223.75
253.40
+23.00 (+ 9.08 %) Prev Close: 230.40 52 Week Range 64.00
235.30
Year End :2018-03 

A. The following explain the material adjustments made while transition from previous Accounting Standards to Ind AS.

a. Fair value of security deposits:

Under the previous GAAP, interest free security deposits are recorded at transactions value. Under Ind AS, all financial assets are required to be fair valued.

b. Other comprehensive income:

Under Ind AS all items of income and expenses recognised in the period should be included in the profit & loss for the period, unless a Standard requires or permits otherwise.

Items of income and expenses that are not recognised in the statement of profit & loss but are shown in the statement of profit or loss as other comprehensive income includes re-measurement of defined benefit plans. The concept of other comprehensive income did not exist under previous GAAP.

c. Deferred tax :

Deferred tax impact on the above adjustments.

d. Retained earnings:

Retained earnings as at 1st April, 2016 has been adjusted consequent to the above Ind AS transition adjustments.

B. Summary of the Company’s exposure to credit risk by age of the outstanding from various customers is as follows:

The Ageing analysis of Account receivables has been considered from the date the invoice falls due:

C. Capital Management

The company’s objectives when managing capital are to

i) Safeguard their ability to continue as a going concern, so that they can continue to provide returns for shareholders and benefits for other stakeholders, and maintain an optimal capital structure to reduce the cost of capital. The Company monitors capital using a ratio of ‘adjusted net debt’ to ‘adjusted equity’. For this purpose, adjusted net debt is defined as total liabilities, comprising interest-bearing loans and borrowings and obligations under finance leases, less cash and cash equivalents. Adjusted equity comprises all components of equity.

D. Balance of Trade Receivables and Trade payable are subject to confirmations

I. SEGMENT INFORMATION_

Based on the guiding principles given in the Accounting Standard 17 on “Segment Reporting” issued by The Institute of Chartered Accountants of India, the Company is a single segment Company engaged in the business of Bulk Drugs.

II. Previous year’s figures have been regrouped, rearranged and reclassified wherever necessary.